Five Prime Therapeutics Inc (NASDAQ:FPRX)

16.76
Delayed Data
As of 10:08am ET
 -0.12 / -0.71%
Today’s Change
15.66
Today|||52-Week Range
48.87
-23.54%
Year-to-Date
No recent news for Five Prime Therapeutics Inc.

Today’s Trading

Previous close16.88
Today’s open16.77
Day’s range16.68 - 17.10
Volume17,682
Average volume (3 months)565,541
Market cap$672.8M
Data as of 10:08am ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)-120.49%
Earnings growth (this year)+23.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+28.73%
P/E ratioNM
Price/Sales15.50
Price/Book2.05

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc+0.19+0.72%
EDITEditas Medicine Inc+0.46+1.30%
MYOVMyovant Sciences Ltd-0.12-0.53%
EPZMEpizyme Inc-0.30-1.81%
Data as of 10:20am ET, 04/19/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)-$1.12
Annual revenue (last year)$39.5M
Annual profit (last year)-$150.2M
Net profit margin-380.23%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Aron M. Knickerbocker
Chief Financial &
Accounting Officer
Linda M. Rubinstein
Corporate headquarters
South San Francisco, California

Forecasts